Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · IEX Real-Time Price · USD
1.660
-0.075 (-4.32%)
At close: Jul 19, 2024, 4:00 PM
1.700
+0.040 (2.41%)
Pre-market: Jul 22, 2024, 7:36 AM EDT
PACB Market Cap
PACB has a market cap or net worth of $452.11 million as of July 22, 2024. Its market cap has decreased by -85.13% in one year.
Market Cap
452.11M
Enterprise Value
821.26M
1-Year Change
-85.13%
Ranking
Category
Stock Price
$1.66
Market Cap Chart
Since October 27, 2010, PACB's market cap has decreased from $823.90M to $452.11M, a decrease of -45.13%. That is a compound annual growth rate of -4.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 452.10M | -82.77% |
| Dec 29, 2023 | 2.62B | 41.85% |
| Dec 30, 2022 | 1.85B | -59.02% |
| Dec 31, 2021 | 4.51B | -3.45% |
| Dec 31, 2020 | 4.67B | 494.29% |
| Dec 31, 2019 | 786.60M | -28.61% |
| Dec 31, 2018 | 1.10B | 259.04% |
| Dec 29, 2017 | 306.90M | -12.84% |
| Dec 30, 2016 | 352.10M | -65.19% |
| Dec 31, 2015 | 1.01B | 80.82% |
| Dec 31, 2014 | 559.40M | 61.68% |
| Dec 31, 2013 | 346.00M | 262.30% |
| Dec 31, 2012 | 95.50M | -37.79% |
| Dec 30, 2011 | 153.50M | -81.73% |
| Dec 31, 2010 | 840.40M | 2.00% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anavex Life Sciences | 463.84M |
| MaxCyte | 459.99M |
| EyePoint Pharmaceuticals | 458.34M |
| Bioventus | 457.64M |
| Voyager Therapeutics | 455.27M |
| Absci | 448.94M |
| Altimmune | 445.27M |
| Nano-X Imaging | 441.43M |